| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.8 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.8 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.0068 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |